Keywords: Pfizer, Inspra, Trial stopped early on success, Heart failure

Pfizer halts cardiovascular drug Inspra trial recruitment on positive results

Article | 28 May 2010

Print This

US global drugs behemoth Pfizer says that it plans to halt recruitment to the EMPHASIS-HF trial, assessing Inspra (eplerenone), early ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in